Literature DB >> 20696983

Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium.

Augusto C Montezano1, Deborah Zimmerman, Hiba Yusuf, Dylan Burger, Andreia Z Chignalia, Vishal Wadhera, Frank N van Leeuwen, Rhian M Touyz.   

Abstract

Arterial calcification, common in vascular diseases, involves vascular smooth muscle cell (VSMC) transformation to an osteoblast phenotype. Clinical studies suggest that magnesium may prevent this, but mechanisms are unclear. We assessed whether increasing magnesium levels reduce VSMC calcification and differentiation and questioned the role of the Mg(2+) transporter, transient receptor potential melastatin (TRPM)7 cation channels in this process. Rat VSMCs were exposed to calcification medium in the absence and presence of magnesium (2.0 to 3.0 mmol/L) or 2-aminoethoxy-diphenylborate (2-APB) (TRPM7 inhibitor). VSMCs from mice with genetically low (MgL) or high-normal (MgH) [Mg(2+)](i) were also studied. Calcification was assessed by von Kossa staining. Expression of osteocalcin, osteopontin, bone morphogenetic protein (BMP)-2, BMP-4, BMP-7, and matrix Gla protein and activity of TRPM7 (cytosol:membrane translocation) were determined by immunoblotting. Calcification medium induced osteogenic differentiation, reduced matrix Gla protein content, and increased expression of the sodium-dependent cotransporter Pit-1. Magnesium prevented calcification and decreased osteocalcin expression and BMP-2 activity and increased expression of calcification inhibitors, osteopontin and matrix Gla protein. TRPM 7 activation was decreased by calcification medium, an effect reversed by magnesium. 2-APB recapitulated the VSMC osteoblastic phenotype in VSMCs. Osteocalcin was increased by calcification medium in VSMCs and intact vessels from MgL but not MgH, whereas osteopontin was increased in MgH, but not in MgL mice. Magnesium negatively regulates vascular calcification and osteogenic differentiation through increased/restored TRPM7 activity and increased expression of anticalcification proteins, including osteopontin, BMP-7, and matrix Gla protein. New molecular insights are provided whereby magnesium could protect against VSMC calcification.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20696983     DOI: 10.1161/HYPERTENSIONAHA.110.152058

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  71 in total

Review 1.  Vascular calcification in chronic kidney disease: Pathogenesis and clinical implication.

Authors:  Sinee Disthabanchong
Journal:  World J Nephrol       Date:  2012-04-06

Review 2.  Angiotensin II and vascular injury.

Authors:  Augusto C Montezano; Aurelie Nguyen Dinh Cat; Francisco J Rios; Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2014-06       Impact factor: 5.369

Review 3.  Cellular magnesium homeostasis.

Authors:  Andrea M P Romani
Journal:  Arch Biochem Biophys       Date:  2011-05-27       Impact factor: 4.013

4.  A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD.

Authors:  Yusuke Sakaguchi; Takayuki Hamano; Yoshitsugu Obi; Chikako Monden; Tatsufumi Oka; Satoshi Yamaguchi; Isao Matsui; Nobuhiro Hashimoto; Ayumi Matsumoto; Karin Shimada; Yoshitsugu Takabatake; Atsushi Takahashi; Jun-Ya Kaimori; Toshiki Moriyama; Ryohei Yamamoto; Masaru Horio; Koichi Yamamoto; Ken Sugimoto; Hiromi Rakugi; Yoshitaka Isaka
Journal:  J Am Soc Nephrol       Date:  2019-04-29       Impact factor: 10.121

Review 5.  Mitral Annular Calcification: Association with Atherosclerosis and Clinical Implications.

Authors:  Luiz Rafael P Cavalcanti; Michel Pompeu B O Sá; Álvaro M Perazzo; Antonio C Escorel Neto; Rafael A F Gomes; Alexander Weymann; Konstantin Zhigalov; Arjang Ruhparwar; Ricardo C Lima
Journal:  Curr Atheroscler Rep       Date:  2020-02-07       Impact factor: 5.113

6.  Aldosterone, inactive matrix gla-protein, and large artery stiffness in hypertension.

Authors:  Julio A Chirinos; Mayank Sardana; Amer Ahmed Syed; Maheshwara R Koppula; Swapna Varakantam; Izzah Vasim; Harold G Oldland; Timothy S Phan; Nadja E A Drummen; Cees Vermeer; Raymond R Townsend; Scott R Akers; Wen Wei; Edward G Lakatta; Olga V Fedorova
Journal:  J Am Soc Hypertens       Date:  2018-06-30

Review 7.  Clinical features of CKD-MBD in Japan: cohort studies and registry.

Authors:  Takayuki Hamano; Yusuke Sakaguchi; Naohiko Fujii; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2016-12-09       Impact factor: 2.801

8.  Magnesium intake is inversely associated with coronary artery calcification: the Framingham Heart Study.

Authors:  Adela Hruby; Christopher J O'Donnell; Paul F Jacques; James B Meigs; Udo Hoffmann; Nicola M McKeown
Journal:  JACC Cardiovasc Imaging       Date:  2013-11-27

Review 9.  Chronic Kidney Disease-Mineral and Bone Disorders: Pathogenesis and Management.

Authors:  Jorge B Cannata-Andía; Beatriz Martín-Carro; Julia Martín-Vírgala; Javier Rodríguez-Carrio; José Joaquín Bande-Fernández; Cristina Alonso-Montes; Natalia Carrillo-López
Journal:  Calcif Tissue Int       Date:  2020-11-15       Impact factor: 4.333

10.  Long-term proton pump inhibitor use is associated with vascular calcification in chronic kidney disease: a cross-sectional study using propensity score analysis.

Authors:  Maria Fusaro; Marianna Noale; Giovanni Tripepi; Sandro Giannini; Angela D'Angelo; Angelo Pica; Lorenzo A Calò; Davide Miozzo; Maurizio Gallieni
Journal:  Drug Saf       Date:  2013-08       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.